1. Home
  2. RMD vs TCOM Comparison

RMD vs TCOM Comparison

Compare RMD & TCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • TCOM
  • Stock Information
  • Founded
  • RMD 1989
  • TCOM 1999
  • Country
  • RMD United States
  • TCOM Singapore
  • Employees
  • RMD N/A
  • TCOM N/A
  • Industry
  • RMD Medical/Dental Instruments
  • TCOM Hotels/Resorts
  • Sector
  • RMD Health Care
  • TCOM Consumer Discretionary
  • Exchange
  • RMD Nasdaq
  • TCOM Nasdaq
  • Market Cap
  • RMD 36.5B
  • TCOM 38.7B
  • IPO Year
  • RMD 1995
  • TCOM 2003
  • Fundamental
  • Price
  • RMD $243.68
  • TCOM $63.72
  • Analyst Decision
  • RMD Buy
  • TCOM Strong Buy
  • Analyst Count
  • RMD 11
  • TCOM 10
  • Target Price
  • RMD $227.63
  • TCOM $74.18
  • AVG Volume (30 Days)
  • RMD 967.8K
  • TCOM 3.5M
  • Earning Date
  • RMD 01-22-2025
  • TCOM 11-18-2024
  • Dividend Yield
  • RMD 0.87%
  • TCOM N/A
  • EPS Growth
  • RMD 22.60
  • TCOM 50.61
  • EPS
  • RMD 7.54
  • TCOM 3.40
  • Revenue
  • RMD $4,807,485,000.00
  • TCOM $7,252,833,407.00
  • Revenue This Year
  • RMD $10.09
  • TCOM $19.96
  • Revenue Next Year
  • RMD $7.15
  • TCOM $15.03
  • P/E Ratio
  • RMD $32.33
  • TCOM $18.70
  • Revenue Growth
  • RMD 9.88
  • TCOM 29.74
  • 52 Week Low
  • RMD $151.95
  • TCOM $32.42
  • 52 Week High
  • RMD $260.49
  • TCOM $69.67
  • Technical
  • Relative Strength Index (RSI)
  • RMD 52.41
  • TCOM 52.92
  • Support Level
  • RMD $231.17
  • TCOM $59.05
  • Resistance Level
  • RMD $255.16
  • TCOM $65.58
  • Average True Range (ATR)
  • RMD 5.36
  • TCOM 1.52
  • MACD
  • RMD -0.20
  • TCOM -0.33
  • Stochastic Oscillator
  • RMD 52.13
  • TCOM 49.41

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from its online platform, but the company also maintains offline call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

Share on Social Networks: